Diagnostic Imaging Global Market Report 2026

Diagnostic imaging refers to the application of sophisticated medical technologies to create detailed visual representations of the body's internal organs, tissues, and anatomical structures. It allows healthcare practitioners to effectively detect, diagnose, and monitor a wide range of diseases, injuries, and health conditions. The primary objective of diagnostic imaging is to support early identification of medical issues, assist in treatment planning, and evaluate patient response throughout the course of care.

The primary offerings of diagnostic imaging consist of hardware, software, contrast agents and accessories, and services. Hardware comprises medical imaging devices utilized to capture detailed views of internal body structures for precise diagnosis and effective treatment planning. The different applications include oncology, neurology, cardiology, gynecology, orthopedics, and others, and these solutions are utilized by various end users such as hospitals, diagnostic centers, and others.

Tariffs are influencing the diagnostic imaging market by increasing the cost of imported imaging equipment, semiconductor components, detector assemblies, contrast agents, and medical device manufacturing inputs used for diagnostic procedures. This is affecting pricing and generating supply chain disruptions, resulting in higher operational expenses for healthcare providers and slower procurement cycles for imaging equipment. Hardware-intensive segments such as CT scanners, MRI systems, ultrasound imaging systems, and hybrid imaging systems are most affected, particularly in import-dependent regions across Asia-Pacific and Latin America. However, tariffs are also driving local manufacturing, supplier diversification, and greater investment in domestic medical technology ecosystems, fostering long-term market resilience.

The diagnostic imaging market size has grown steadily in recent years. It will grow from $34.43 billion in 2025 to $36 billion in 2026 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to increasing investments in healthcare infrastructure, rising prevalence of chronic diseases, growing adoption of advanced imaging technologies, expansion of hospital diagnostic capabilities, and increasing demand for accurate disease diagnosis services.

The diagnostic imaging market size is expected to see steady growth in the next few years. It will grow to $43.39 billion in 2030 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to increasing aging population globally, rising demand for personalized medical solutions, growing adoption of portable imaging technologies, expansion of preventive healthcare programs, and increasing healthcare spending in emerging economies. Major trends in the forecast period include rising demand for early disease detection technologies, growing adoption of portable diagnostic imaging systems, increasing preference for minimally invasive diagnostic procedures, expansion of imaging utilization in chronic disease management, and growing demand for high-resolution and multi-modality imaging solutions.

The rising burden of infectious diseases is expected to drive the growth of the diagnostic imaging market going forward. Infectious diseases are illnesses caused by pathogens such as viruses, bacteria, fungi, or parasites that can spread between individuals or through environmental exposure. The increasing burden of infectious diseases is primarily driven by declining global immunization coverage, as gaps in vaccination programs allow highly contagious pathogens to circulate and trigger large-scale outbreaks across multiple regions. The growing incidence of infectious diseases increases the need for advanced imaging modalities such as chest X-rays and CT scans, which are essential tools for detecting pulmonary complications, organ involvement, and disease progression in affected patients. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. Therefore, the rising burden of infectious diseases is driving the growth of the diagnostic imaging market.

Key companies operating in the diagnostic imaging market are focusing on developing advanced imaging platforms, such as helium-efficient MRI systems, to improve sustainability, enhance operational efficiency, and expand access to diagnostic services. Helium-efficient MRI systems refer to advanced magnetic resonance imaging technologies designed to significantly reduce helium consumption while maintaining high-quality imaging performance and system reliability. In February 2025, GE HealthCare, a US-based medical technology company, launched its Freelium, a magnetic resonance imaging (MRI) platform to support sustainability goals and improve imaging accessibility. The platform uses less than 1% of the helium required by conventional MRI systems, reducing dependence on scarce resources while enabling efficient installation and reliable imaging performance across healthcare facilities. The Freelium platform also features a lightweight system architecture, advanced AI-enabled imaging capabilities, remote service support, and faster workflow integration to enhance diagnostic precision and operational productivity.

In April 2024, GE HealthCare, a US-based health technology company, acquired MIM Software Inc. for an undisclosed amount. With this acquisition, GE HealthCare aims to enhance its precision care approach by integrating advanced imaging analysis, AI-powered image interpretation, and automated workflows to improve clinical efficiency and patient care across multiple therapeutic areas. MIM Software Inc. is a US-based developer of vendor-neutral medical imaging software solutions used in radiology, nuclear medicine, molecular imaging, theranostics, and radiation oncology.

Major companies operating in the diagnostic imaging market are Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., FUJIFILM Holdings Corporation, Canon Inc., Hologic Inc., Mindray Medical International Ltd., Carestream Health Inc., Konica Minolta Inc., Shimadzu Corporation, Agfa-Gevaert N.V., Varex Imaging Corporation, Guerbet SA, United Imaging Healthcare Co. Ltd., Neusoft Medical Systems Co. Ltd., Esaote S.p.A., Samsung HME America, RadNet Inc., Allengers Medical Systems Limited, CurveBeam AI Ltd., Planmed Oy, JSC Amico, SternMed GmbH, Koning Health Inc.

North America was the dominant region in the diagnostic imaging market in 2025. Asia-Pacific is expected to be the rapidly expanding regionin the forecast period. The regions covered in the diagnostic imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the diagnostic imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diagnostic imaging market consists of revenues earned by entities by providing services such as radiology services, imaging diagnostics, teleradiology services, image interpretation services, medical imaging reporting, and diagnostic scan services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diagnostic imaging market also includes sales of MRI scanners, CT scanners, X-ray machines, ultrasound machines, PET scanners, SPECT scanners, and mammography systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The diagnostic imaging market research report is one of a series of new reports from The Business Research Company that provides diagnostic imaging market statistics, including diagnostic imaging industry global market size, regional shares, competitors with a diagnostic imaging market share, detailed diagnostic imaging market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic imaging industry. This diagnostic imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Diagnostic Imaging Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses diagnostic imaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diagnostic imaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diagnostic imaging market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Offering: Hardware; Software; Contrast Agents And Accessories; Services
• 2) By Application: Oncology; Neurology; Cardiology; Gynecology; Orthopedics; Other Applications
• 3) By End User: Hospitals; Diagnostic Center; Other End Users
• Subsegments:
• 1) By Hardware: X-ray Systems; Computed Tomography (CT) Scanners; Magnetic Resonance Imaging (MRI) Systems; Ultrasound Imaging Systems; Nuclear Imaging Systems; Mammography Systems; Fluoroscopy Systems; Hybrid Imaging Systems; Portable Imaging Devices; Image-Guided Intervention Systems
• 2) By Software: Picture Archiving And Communication System (PACS); Radiology Information System (RIS); Advanced Visualization Software; AI-Based Imaging Analysis Software; 3D Or 4D Imaging Software; Workflow Management Software; Reporting And Diagnostic Software; Image Reconstruction Software; Cloud-Based Imaging Software; Vendor Neutral Archive (VNA) Software
• 3) By Contrast Agents And Accessories: Iodinated Contrast Media; Gadolinium-Based Contrast Media; Microbubble Contrast Agents; Barium-Based Contrast Media; Injectors And Syringes; Catheters And Tubing Sets; Imaging Coils; Detector Panels; Protective Shields And Aprons; Positioning And Immobilization Accessories
• 4) By Services: Installation And Integration Services; Maintenance And Repair Services; Training And Education Services; Managed Imaging Services; Remote Monitoring Services; Consulting Services; Teleradiology Services; Equipment Upgrade Services; Calibration Services; Software Support And IT Services
• Companies Mentioned: Siemens Healthineers AG; GE HealthCare Technologies Inc.; Koninklijke Philips N.V.; FUJIFILM Holdings Corporation; Canon Inc.; Hologic Inc.; Mindray Medical International Ltd.; Carestream Health Inc.; Konica Minolta Inc.; Shimadzu Corporation; Agfa-Gevaert N.V.; Varex Imaging Corporation; Guerbet SA; United Imaging Healthcare Co. Ltd.; Neusoft Medical Systems Co. Ltd.; Esaote S.p.A.; Samsung HME America; RadNet Inc.; Allengers Medical Systems Limited; CurveBeam AI Ltd.; Planmed Oy; JSC Amico; SternMed GmbH; Koning Health Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.